Rating Flow: Is EKF Diagnostics Holdings PLC (LON:EKF) Worth Your Time After Placed Under Review from finnCap?

November 29, 2016 - By Ruchi Gupta

EKF Diagnostics Holdings PLC (LON:EKF) Surprise By finnCap

EKF Diagnostics Holdings PLC (LON:EKF) stock had its under review rating reaffirmed by stock research analysts at finnCap in a research note revealed to investors on 29 November.

Ekf Diagnostics Holding PLC (LON:EKF) Ratings Coverage

Out of 3 analysts covering EKF Diagnostics Holdings PLC (LON:EKF), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. GBX 30 is the highest target while GBX 14 is the lowest. The GBX 24 average target is 40.27% above today’s (GBX 17.11) stock price. EKF Diagnostics Holdings PLC has been the topic of 28 analyst reports since August 19, 2015 according to StockzIntelligence Inc. The stock of Ekf Diagnostics Holding PLC (LON:EKF) has “Buy” rating given on Thursday, September 3 by FinnCap. FinnCap maintained the shares of EKF in a report on Monday, September 28 with “Buy” rating. FinnCap maintained Ekf Diagnostics Holding PLC (LON:EKF) on Friday, September 18 with “Buy” rating. The rating was maintained by Panmure Gordon with “Buy” on Wednesday, July 6. The rating was maintained by FinnCap on Tuesday, November 17 with “Buy”. The firm has “Buy” rating given on Monday, September 5 by Panmure Gordon. N+1 Singer maintained the stock with “Corporate” rating in Friday, October 7 report. FinnCap maintained it with “Buy” rating and GBX 30 target price in Monday, August 24 report. As per Wednesday, August 19, the company rating was maintained by FinnCap. The stock of Ekf Diagnostics Holding PLC (LON:EKF) has “Buy” rating given on Monday, November 7 by Panmure Gordon.

Ekf Diagnostics Holding PLC (LON:EKF) has risen 63.53% since April 28, 2016 and is uptrending. It has outperformed by 58.27% the S&P500.

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of services and products into the in-vitro diagnostic market place. The company has a market cap of 80.09 million GBP. The Firm makes and sells diagnostic instruments, reagents and certain ancillary products. It currently has negative earnings. The Company’s point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases.

More important recent Ekf Diagnostics Holding PLC (LON:EKF) news were published by: Fool.Co.Uk which released: “Are These 3 Small-Caps Set To Soar? EKF Diagnostics Holding PLC, Hardy Oil …” on March 18, 2016, also Fool.Co.Uk published article titled: “Why Shares In EKF Diagnostics Holding PLC Halved Today”, Fool.Co.Uk published: “Should you buy Topps Tiles plc, EKF Diagnostics Holding plc and Low & Bonar …” on July 06, 2016. More interesting news about Ekf Diagnostics Holding PLC (LON:EKF) was released by: Fool.Co.Uk and their article: “Why Ekf Diagnostics Holding PLC Has Tumbled Today” with publication date: September 15, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News